These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 39281394)

  • 1. Comparison between the Efficacy and Tolerability of Polyvinylpyrrolidone-Iodine Eye Drops 0.6% and 1% in Adenoviral Keratoconjunctivitis: A Randomized Clinical Trial.
    Makateb A; Soleymanzadeh M; Soleiman-Meigooni S; Asgari A; Etemadi MR; Mafi AR; Mohammadi N
    J Curr Ophthalmol; 2023; 35(4):337-344. PubMed ID: 39281394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis.
    Liu SH; Hawkins BS; Ng SM; Ren M; Leslie L; Han G; Kuo IC
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013520. PubMed ID: 35238405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study.
    Kovalyuk N; Kaiserman I; Mimouni M; Cohen O; Levartovsky S; Sherbany H; Mandelboim M
    Acta Ophthalmol; 2017 Dec; 95(8):e686-e692. PubMed ID: 28342227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of polyvinylpyrrolidone-iodine 0.6% treatment in adenoviral keratoconjunctivitis: a Prospective Randomized Controlled Study.
    Ricciardelli G; Giannaccare G; Di Zazzo A; Coassin M; Scorcia V; Romano MR; Allegrini D; Cennamo M; Antonini M; Bernabei F; Morelli A; Mencucci R
    Eye (Lond); 2022 Jan; 36(1):160-166. PubMed ID: 33654316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of diluted povidone iodine in adenoviral keratoconjunctivitis on the rate of subepithelial corneal infiltrates.
    Altan-Yaycioglu R; Sahinoglu-Keskek N; Canan H; Coban-Karatas M; Ulas B
    Int J Ophthalmol; 2019; 12(9):1420-1425. PubMed ID: 31544037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of povidone-iodine 2% eye drops in the treatment of adenoviral keratoconjunctivitis.
    Soleimani M; Tabatabaei SA; Mirzaei A; Esfandiari A; Soleymanzadeh M; Sadeghi R; Rad AH
    Oman J Ophthalmol; 2023; 16(1):69-74. PubMed ID: 37007229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone/Povidone Eye Drops versus Artificial Tears for Treatment of Presumed Viral Conjunctivitis: A Randomized Clinical Trial.
    Pinto RD; Lira RP; Abe RY; Zacchia RS; Felix JP; Pereira AV; Arieta CE; de Castro RS; Bonon SH
    Curr Eye Res; 2015 Sep; 40(9):870-7. PubMed ID: 25310347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and tolerability of a one-time, in-office administration of 5% povidone-iodine in the treatment of adenoviral conjunctivitis: The Reducing Adenoviral Patient Infected Days (RAPID) study.
    Shorter E; Whiteside M; Harthan J; Margolis MS; Hartwick AT; Johnson S; Migneco M; Morettin C; Olson CK; Huecker J; Than T; Gordon MO
    Ocul Surf; 2019 Oct; 17(4):828-832. PubMed ID: 31401340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A treatment protocol for minimizing duration and complications of adenoviral epidemic keratoconjunctivitis.
    Kulkarni C; Ballal K
    Taiwan J Ophthalmol; 2020; 10(4):269-277. PubMed ID: 33437600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin A eye drop and subepithelial adenoviral keratoconjunctivitis infiltrates.
    Zghal I; Fekih O; Zgolli HM; Chargui S; Malek I; Nacef L
    Tunis Med; 2019 May; 97(5):639-643. PubMed ID: 31729734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, Controlled, Phase 2 Trial of Povidone-Iodine/Dexamethasone Ophthalmic Suspension for Treatment of Adenoviral Conjunctivitis.
    Pepose JS; Ahuja A; Liu W; Narvekar A; Haque R
    Am J Ophthalmol; 2018 Oct; 194():7-15. PubMed ID: 29787732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a Single Administration of 5% Povidone-Iodine in the Treatment of Adenoviral Conjunctivitis.
    Than T; Morettin CE; Harthan JS; Hartwick ATE; Huecker JB; Johnson SD; Migneco MK; Shorter E; Whiteside M; Olson CK; Alferez CS; van Zyl T; Rodic-Polic B; Storch GA; Gordon MO
    Am J Ophthalmol; 2021 Nov; 231():28-38. PubMed ID: 34102153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study.
    Hillenkamp J; Reinhard T; Ross RS; Böhringer D; Cartsburg O; Roggendorf M; De Clercq E; Godehardt E; Sundmacher R
    Arch Ophthalmol; 2001 Oct; 119(10):1487-91. PubMed ID: 11594949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical Pharmacologic Interventions Versus Active Control, Placebo, or No Treatment for Epidemic Keratoconjunctivitis: Findings From a Cochrane Systematic Review.
    Liu SH; Hawkins BS; Ren M; Ng SM; Leslie L; Han G; Kuo IC
    Am J Ophthalmol; 2022 Aug; 240():265-275. PubMed ID: 35331686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study.
    Hillenkamp J; Reinhard T; Ross RS; Böhringer D; Cartsburg O; Roggendorf M; De Clercq E; Godehardt E; Sundmacher R
    Ophthalmology; 2002 May; 109(5):845-50. PubMed ID: 11986086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of ozonized oil and a combination of tobramycin/dexamethasone eye drops in the treatment of viral conjunctivitis: a randomized clinical trial.
    Cagini C; Mariniello M; Messina M; Muzi A; Balducci C; Moretti A; Levorato L; Mencacci A
    Int Ophthalmol; 2020 Dec; 40(12):3209-3215. PubMed ID: 32696102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Use of Bandage Contact Lenses in Adenoviral Keratoconjunctivitis.
    Uçakhan Ö; Yanik Ö
    Eye Contact Lens; 2016 Nov; 42(6):388-391. PubMed ID: 26671622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Treatment Models for Adenoviral Keratoconjunctivitis in the Childhood Population.
    Bekmez S; Eris E
    Ocul Immunol Inflamm; 2021 Nov; 29(7-8):1627-1632. PubMed ID: 32643975
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized controlled trial of povidone-iodine/dexamethasone ophthalmic suspension for acute viral conjunctivitis.
    Pepose JS; Narvekar A; Liu W; Haque R
    Clin Ophthalmol; 2019; 13():535-544. PubMed ID: 30962674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of clinical outcome with different treatment regimens in acute adenoviral keratoconjunctivitis.
    Asena L; Şıngar Özdemir E; Burcu A; Ercan E; Çolak M; Altınörs DD
    Eye (Lond); 2017 May; 31(5):781-787. PubMed ID: 28157224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.